Three vaccines that are currently used, namely those manufactured by Sinovac, AstraZeneca, and Sinopharm, are listed on the WHO’s emergency use listing.
"Vaccines provided or prepared by Ministry of Health are vaccines that have been tested and fulfilled the aspects of security, efficacy, and quality. It is indicated with the issuance of emergency use authorization for the vaccine products,” said the Ministry's General Secretary Oscar Primadi, as quoted from the Cabinet Secretariat's website.
On Monday, as many as 10 million Sinovac-manufactured covid-19 vaccines in the form of raw material or bulk arrived at Soekarno-Hatta airport in Tangerang city, Banten province.
With the arrival of this vaccine batch, the total number of vaccines Indonesia has received is 104,728,400 doses which consist of 94.5 million doses of Sinovac-manufactured vaccine, 8,228,400 doses of Astra-Zeneca vaccine, and two million doses of Sinopharm vaccine.
According to Oscar, the addition of these vaccine bulks will support the Government’s measure to speed up the ongoing covid-19 vaccination.